Sofie Bjärtun

Member of the Swedish Bar Association
  • Stockholm
  • Languages:
    Swedish, English, French, German

Education

  • Lund University,  LL.M., 2013
  • McGill University, Montreal, Canada, 2011-2012

Experience

  • Bird & Bird, Stockholm, summer trainee, 2012
  • Norton Rose LLP, London, summer trainee, 2012
  • Vinge, Stockholm, summer trainee, 2011
  • Norton Rose LLP, Frankfurt, summer intern, 2010

Mandates

Mandate October 16, 2020

Vinge has advised Oncopeptides in connection with entering into agreements regarding a loan facility of up to EUR 40 million from the EIB

The loan agreement with the EIB grants Oncopeptides access to an unsecured loan facility of up to EU…

Mandate August 13, 2020

Vinge advises Calliditas Therapeutics in connection with acquisition of controlling interest in Genkyotex SA

Vinge advises Calliditas Therapeutics, a specialty pharmaceutical company listed on Nasdaq Stockholm…

Mandate June 11, 2020

Vinge advises Medicover in connection with a directed share issue 

The board of directors of Medicover has, on the basis of an authorisation granted from the annual ge…

Mandate June 10, 2020

Vinge advises Calliditas

Vinge advises Calliditas Therapeutics in connection with its capital raising and listing on The Nasd…

Mandate May 11, 2020

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncop…

Mandate January 10, 2020

Vinge has advised Industrifonden and Investinor in connection with a sale of shares in Calliditas

Vinge has advised Industrifonden and Investinor in connection with a sale of in total approximately…

Mandate September 24, 2019

Vinge has advised EQT AB (publ) in connection with the listing on Nasdaq Stockholm

Vinge has advised EQT AB (publ) (“EQT”) in connection with the offering and listing on Nasdaq Stockh…

Mandate June 28, 2019

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncop…

Mandate April 25, 2019

Vinge advises Finanzero Brazil in connection with capital raising

Vinge advises Finanzero in connection with the company's capital raising of approximately SEK 100 mi…

Mandate August 17, 2018

Vinge assisted Industrifonden in connection with the sale of shares in Oncopeptides AB (publ) through an accelerated bookbuilding process

In total, 1,2 million shares were placed at a price of SEK 148 per share, corresponding to a total v…

Mandate June 29, 2018

Vinge advises Calliditas Therapeutics in connection with the listing on Nasdaq Stockholm’s main market

Vinge advises Calliditas Therapeutics AB (publ) (“Calliditas Therapeutics”) in connection with the l…

Mandate June 20, 2018

Vinge advises ABG, SEB and Swedbank in connection with a directed share issue in Hemfosa

Vinge advises ABG Sundal Collier, Skandinaviska Enskilda Banken and Swedbank who are acting as Joint…

Mandate May 24, 2018

Vinge advises IRLAB Therapeutics in connection with a directed share issue

The board of directors of IRLAB Therapeutics has, on the basis of an authorisation granted from the…

Mandate April 05, 2018

Vinge advises Finanzero in connection with capital raising

Vinge advises Finanzero in connection with the company's capital raising of approximately SEK 30 mil…

Mandate March 23, 2018

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncop…

Mandate January 24, 2018

Vinge has advised Pandox in connection with acquisition and directed share issue

Vinge has advised Pandox Aktiebolag (publ) with certain financing and capital markets related questi…

Mandate June 26, 2017

Vinge assisted EQT V Limited in connection with the sale of shares in AcadeMedia AB (publ)

Vinge assisted EQT V Limited (”EQT”) in connection with the sale of shares in AcadeMedia AB (publ) (…

Mandate June 07, 2017

Vinge advises DGC in connection with EQT’s acquisition of shares in DGC and subsequent mandatory offer

Vinge advises DGC One AB (publ) (“DGC”) in connection with EQT’s acquisition of 85.2 percent of the…

Mandate May 23, 2017

Vinge advises Medicover in relation to its listing on Nasdaq Staockholm

Vinge advises Medicover AB (publ) (“Medicover”) and its main shareholder Celox Holding AB (“Celox”),…

News

New partners and counsels appointed at Vinge’s Stockholm office
News July 06, 2021

New partners and counsels appointed at Vinge’s Stockholm office

Advokat Sofie Bjärtun, advokat Rikard Lindahl, advokat Malin Malm Waerme and advokat Daniel Wendelss…